April 2008- Volume 4, Issue 4
April 2008
In this Issue
Genomics & Proteomics
Some Texas teamwork
Some Texas teamwork
Houston company signs proteomic tech agreement with MD Anderson
Extending half-lives, cutting costs for proteins
Extending half-lives, cutting costs for proteins
Novozymes licenses albufuse technology to CSL Behring for therapeutic protein work
Probing the Parsi people
Probing the Parsi people
AVESTAGENOME Project to study genetic causes of Parsi longevity
Silence's siRNA is golden
Silence's siRNA is golden
Silence Therapeutics and AstraZeneca strike new deal to design ways of delivering siRNA therapeutics
Putting the brakes on cancer?
Putting the brakes on cancer?
Yale, Asuragen scientists show miRNA can reduce lung cancer growth
Research & Development
Critical path thinking
Critical path thinking
Immune Tolerance Institute, in collaboration with Beckman Coulter, establishes the Center for Critical Path Immunology
Kantor appointed chief scientific officer for ITI
Kantor appointed chief scientific officer for ITI
Earlier this month, the Immune Tolerance Institute Inc. (ITI) announced that Aaron B. Kantor, Ph.D. has joined the company in the position of chief scientific officer, reporting to Louis A. Matis, M.D., president and CEO.
Lilly, Transition to tackle diabetes
Lilly, Transition to tackle diabetes
Companies to explore gastrin-based therapies to regenerate insulin-producing cells
Lilly taps Suven for CNS research
Lilly taps Suven for CNS research
Collaboration to broaden preclinical research of CNS molecules
BioInvent and Bayer seal therapeutic antibody deal
BioInvent and Bayer seal therapeutic antibody deal
BioInvent International AB in March struck a deal with Bayer HealthCare related to the discovery and development of antibody products under which Bayer will have a non-exclusive research license for the use of BioInvent’s proprietary n-CoDeR library for the discovery of human monoclonal antibodies.
Next gen stem cell research
Next gen stem cell research
VistaGen, McEwen Centre to advance embryonic stem cell technologies
Informatics
Capturing the EDC market
Capturing the EDC market
Bio-Imaging Technologies acquires Phoenix Data Systems for $24 million
75 different translations
75 different translations
RemedyMD, GulfSream Bioinformatics merge software for translational research solutions
From co-marketing to embedded partners
From co-marketing to embedded partners
Agilent, Accelrys take partnership to the next level
Quantum leap ahead
Quantum leap ahead
QuantumBio Inc. recently netted a FastTrack Small Business Innovation Research Grant (SBIR) of more than $865,000 from the NIH for research and development of novel, quantum mechanics-based methodologies for protein/drug scoring and interaction decomposition to help better understand protein-drug interactions.
Swimming upstream
Swimming upstream
Medidata-Fast Track partnership seeks end-to-end trial process efficiencies
Automation & Instrumentation
Getting with the flow
Getting with the flow
Millipore, Guava team up to create new flow cytometry solutions for the cell biology market
RAPid move for discovery
RAPid move for discovery
TTP LabTech gains license to Resonant Acoustic Profiling from Cambridge Medical Innovations
Astech “REACTS” to market
Astech “REACTS” to market
Company hopes to leverage its new automation maintenance service to gain new customers
Genomes for $100?
Genomes for $100?
Battelle Ventures, BioNanomatrix hope to slash genome costs
SmartSlide slips into six foreign markets
SmartSlide slips into six foreign markets
Hoping to set a new standard in cell culture study, WaferGen Biosystems Inc. announced six distributor agreements in as many weeks for the company’s SmartSlide Micro-Incubation System, a first-of-its kind family of integrated fluidics exchange micro-incubation products.
Global News
Teva: Hola, Bentley
Teva: Hola, Bentley
$360M acquisition will allow Teva to capture Bentley’s market share in Spain
Small, but mighty
Small, but mighty
Alimera, pSivida bolster plan to bring DME eye implant to market
Takeda joins HRP Initiative’s fight against high-risk plaque disease
Takeda joins HRP Initiative’s fight against high-risk plaque disease
Japanese pharmaceutical research company Takeda Pharmaceutical Co. Ltd. has joined BG Medicine, Merck, AstraZeneca and Philips as the newest member of the High-Risk Plaque (HRP) Initiative, a pre-competitive industry collaboration working to reduce morbidity, mortality and costs associated with cardiovascular disease.
CBI forms outsourcing services joint venture with Venturepharm
CBI forms outsourcing services joint venture with Venturepharm
With plans to offer a comprehensive suite of outsourcing services to the global pharmaceutical industry, Commonwealth Biotechnologies Inc. (CBI), a provider of research and development products and services to the life sciences industry, has formed a joint venture with Venturepharm Laboratories Ltd. (VPL), a publicly-listed pharmaceutical research service company in Beijing, China.
Editor's Focus
Of baseball and a cognitively-enhanced editor
Of baseball and a cognitively-enhanced editor
I’m not ashamed to say that in the last hour I pumped roughly 200 mg of my favorite drug into my body in an attempt to be ready, focused and able to produce an editorial that is, if not entertaining, at least cogent.
